CuraCell Holding AB
European biotech developing personalized T-cell therapies for solid cancer tumors.
Overview
- Unknown
- Employees
- Unknown
- Revenue
- 2020
- Founded
Key Decision Makers
Håkan Hallberg
CFO
Lucas Arruda
Chief Scientific Officer
Thomas Schlegel
General Counsel
Jonas Båtelson
CEO
+3 more contacts in Funnelfeedr
Description
CuraCell is a European biotech company focused on developing innovative T-cell therapies for the treatment of solid cancer tumors. The company utilizes its proprietary platform, CytoPLY, designed to significantly expand and activate the patient's own tumor-reactive T-cells. Their primary therapeutic...